Georgetown University Hospital’s lab for genetic analysis for breast cancer has closed and is being investigated by federal health officials, according to a Washington Post article (8/5/2010). In addition, tissue samples have been sent to an independent lab for retesting. “Federal officials are continuing to investigate the employee’s allegations, according to an official with the Centers for Medicare and Medicaid Services, the federal agency in charge of overseeing the quality of testing in medical laboratories.” According to the formal complaint filed with the Centers for Medicare and Medicaid Services, there was concern that retesting was taking too long and that the hospital was not sharing the problem with patients. The eleven-month testing period in question began in May, 2009 and involved quality-control testing for HER2, a gene that causes breast tumors more likely to spread or return.
I urge anyone who was tested at Georgetown’s lab during the past year to contact their personal physician to determine whether she should be retested. Experts indicate that treatment should begin within twelve months of diagnosis.
If you have any questions about your legal rights, feel free to contact me at 202-822-1899.
Do you have any questions about this post?
About the author:
Mr. Zambri is a Board-Certified Civil Trial Attorney and Past-President of the Trial Lawyers Association of Metropolitan Washington, D.C. He has been acknowledged by Washingtonian magazine as a “Big Gun” and among the “top 1%” of all of the more than 80,000 lawyers in the Washington metropolitan area. The magazine also acknowledged him as “one of Washington’s best–most honest and effective lawyers” who specializes in medical malpractice matters, product liability claims, and serious automobile accident claims. Mr. Zambri has also been repeatedly named a “Super Lawyer” by Law and Politics magazine (2010)–a national publication that honors the top lawyers in America.
Mr. Zambri is regularly asked to present seminars to lawyers and doctors, as well as both medical and law students concerning medication errors, medical malpractice litigation, and safety improvements.
If you have any questions about your legal rights, please email Mr. Zambri at [email protected] or call him at 202-822-1899.